Personal profile
Area of Expertise
The first aim is to screen compounds that will attenuate the subjective and reinforcing effects of abused drugs as part of a NIDA-funded contract searching for effective treatment drugs for addiction to cocaine, methamphetamine, nicotine, and marijuana.
The second aim is to evaluate the potential abuse liability of novel designer drugs that are increasingly available as "legal" alternatives to controlled substances. We use drug discrimination procedures which assess the subjective effects of common drugs of abuse such as cocaine, methamphetamine, nicotine, and marijuana, with designer drugs like MDMA (Ecstasy), with opioids like morphine, or with hallucinogens like LSD. We also test the reinforcing/rewarding effects of drugs using the conditioned place preference and self-administration assays.
Education/Academic qualification
BA in Behavioral Science, The University of Chicago
MA in Behavior Science, University of Houston
PhD in Psychology , Utah State University
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Evaluation of Abuse Potential
Shetty, R. (PI), Forster, M. (CoI) & Gatch, M. (CoI)
4/02/25 → 29/09/26
Project: Research
-
Evaluation of Abuse Potential
Shetty, R. (PI), Forster, M. (CoI) & Gatch, M. (CoI)
4/02/25 → 29/09/26
Project: Research
-
Evaluation of Abuse Potential
Shetty, R. (PI), Forster, M. (CoI) & Gatch, M. (CoI)
30/09/24 → 29/09/29
Project: Research
-
Using rodent behavioral models
Forster, M. (PI), Gatch, M. (CoI), Shetty, R. (CoI) & Sumien, N. (CoI)
NIDA: National Institute on Drug Abuse
4/01/23 → 3/01/28
Project: Research
-
-
Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: Potential mechanisms
Jung, M. E., Gatch, M. B. & Simpkins, J. W., Jan 2005, In: Experimental Biology and Medicine. 230, 1, p. 8-22 15 p.Research output: Contribution to journal › Short survey › peer-review
-
The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: Recent developments
Jung, M. E., Lal, H. & Gatch, M. B., Jun 2002, In: Neuroscience and Biobehavioral Reviews. 26, 4, p. 429-439 11 p.Research output: Contribution to journal › Review article › peer-review
-
Carisoprodol-mediated modulation of GABA A receptors: In vitro and in vivo studies
Gonzalez, L. A., Gatch, M. B., Taylor, C. M., Bell-Horner, C. L., Forster, M. J. & Dillon, G. H., May 2009, In: Journal of Pharmacology and Experimental Therapeutics. 329, 2, p. 827-837 11 p.Research output: Contribution to journal › Article › peer-review
-
Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys
Negus, S. S., Gatch, M. B., Mello, N. K., Zhang, X. & Rice, K., Jul 1998, In: Journal of Pharmacology and Experimental Therapeutics. 286, 1, p. 362-375 14 p.Research output: Contribution to journal › Article › peer-review
-
Abuse liability of the dietary supplement dimethylamylamine
Dolan, S. B. & Gatch, M. B., 2015, In: Drug and Alcohol Dependence. 146, 1, p. 97-102 6 p.Research output: Contribution to journal › Article › peer-review